“Efficacy of Rifaximin in Diarrhoea Predominant Irritable Bowel Syndrome: A Placebo Controlled Clinical Trial”. 2023. Medicine Today 35 (1): 44-48. https://doi.org/10.3329/medtoday.v35i1.64940.